MarketCap
Facebook
X
TelegramQuarterly report 2023-Q3
added 10-24-2023
NextGen Healthcare DPO Ratio 2011-2026 | NXGN
Annual DPO Ratio NextGen Healthcare
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 14.5 | 14.4 | 8.04 | 6.37 | 7.55 | 18 | 16.4 | 13.1 | 22.1 | 10.9 | 19.1 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 22.1 | 6.37 | 13.7 |
Quarterly DPO Ratio NextGen Healthcare
| 2023-Q3 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.8 | - | - | 6.86 | 2.56 | - | 17.2 | 12.5 | 5.83 | - | 9.5 | 10.4 | 13.1 | 13.3 | 9.54 | 7.15 | 7.83 | 6.33 | 7.29 | 6.93 | 5.48 | 5.36 | 7.32 | 9.18 | 7.42 | 7.59 | 8.95 | 8.03 | 12.4 | 17.2 | 18 | 18.7 | 17 | 13.8 | 13.4 | 14.9 | 13.4 | 10.3 | 8.75 | 4.45 | 9.03 | 15.4 | 9.96 | 21 | 16.8 | 11.9 | 14.2 | 14.9 | 16.2 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 21 | 2.56 | 11.1 |
DPO Ratio of other stocks in the Health information services industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cerner Corporation
CERN
|
103 | - | - | $ 27.9 B |  USA |
 |
Accolade
ACCD
|
14.4 | - | 0.29 % | $ 206 M | USA |
 |
Evolent Health
EVH
|
19.3 | $ 3.95 | 1.28 % | $ 451 M | USA |
 |
Computer Programs and Systems
CPSI
|
38.7 | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
41.9 | - | - | $ 2.94 B | USA |
 |
Castlight Health, Inc.
CSLT
|
36.1 | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
11.7 | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
115 | - | - | $ 6.37 B | USA |
 |
HealthEquity
HQY
|
12.1 | $ 87.99 | -2.79 % | $ 7.58 B | USA |
 |
iCAD
ICAD
|
112 | - | - | $ 102 M | USA |
 |
GoodRx Holdings
GDRX
|
106 | $ 2.92 | -1.68 % | $ 1.04 B | USA |
 |
Akerna Corp.
KERN
|
5.62 | - | - | $ 161 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
32.6 | - | -10.39 % | $ 886 M | USA |
 |
10x Genomics
TXG
|
23.5 | $ 28.31 | 1.13 % | $ 3.53 B | USA |
 |
MTBC
MTBC
|
36.4 | - | -0.58 % | $ 51.7 M | USA |
 |
1Life Healthcare
ONEM
|
14 | - | - | $ 3.37 B | USA |
 |
Premier
PINC
|
28.6 | - | - | $ 2.33 B | USA |
 |
Health Catalyst
HCAT
|
23.8 | $ 1.38 | -1.43 % | $ 96.5 M | USA |
 |
OptimizeRx Corporation
OPRX
|
19.3 | $ 5.19 | 1.76 % | $ 96.3 M | USA |
 |
Schrödinger
SDGR
|
35.6 | $ 15.2 | 7.34 % | $ 1.12 B | USA |
 |
Phreesia
PHR
|
43.7 | $ 9.86 | 4.34 % | $ 589 M | USA |
 |
R1 RCM
RCM
|
5.63 | - | - | $ 3.81 B | USA |
 |
Teladoc Health
TDOC
|
19.2 | $ 7.61 | 1.33 % | $ 1.34 B | USA |
 |
Signify Health
SGFY
|
57.5 | - | -0.02 % | $ 7.21 B | USA |
 |
Streamline Health Solutions
STRM
|
62 | - | - | $ 21.4 M | USA |
 |
NantHealth
NH
|
86.1 | - | -46.64 % | $ 10.4 M | USA |
 |
SCWorx Corp.
WORX
|
43.2 | - | - | $ 7.71 M | USA |
 |
American Well Corporation
AMWL
|
10.4 | $ 9.83 | 3.91 % | $ 158 M | USA |
 |
Tabula Rasa HealthCare
TRHC
|
22.2 | - | - | $ 255 M | USA |
 |
HealthStream
HSTM
|
24.5 | $ 24.97 | 1.38 % | $ 750 M | USA |
 |
Omnicell
OMCL
|
25.7 | $ 44.14 | -1.3 % | $ 2.03 B | USA |
 |
Progyny
PGNY
|
166 | $ 25.56 | -0.51 % | $ 2.18 B | USA |
 |
So-Young International
SY
|
10.8 | $ 1.95 | - | $ 152 M |  China |
 |
Veeva Systems
VEEV
|
15.9 | $ 174.34 | 6.06 % | $ 28.5 B | USA |
 |
Zhongchao
ZCMD
|
31 | $ 0.17 | -69.09 % | $ 581 K | China |